RELATED: Introduction to biosimilars for AMD
November 7th, 2026Takeaways from this week in optometry: November 2-6A wet AMD biosimilar approval leads this week’s recap, plus Medicare pay updates and tips to avoid burnout and losing patients.Read more
November 19th, 2026First patient dosed in EMERALD trial of EO2002 for corneal edemaThe phase 2 EMERALD trial compares 2 doses of EO2002 with placebo, with a 15-letter BCVA gain at 26 weeks as the primary end point.Read more
November 19th, 2026High Point University optometry school earns ACOE preliminary approvalThe school will be admitting its inaugural Doctor of Optometry class in summer 2027, with full accreditation possible in 2030-31.Read more
November 18th, 2026Alice Epitropoulos, MD, on phentolamine for presbyopia treatmentThe FDA approved the Supplemental New Drug Application for phentolamine 0.75% (Ryzumvi, Opus Genetics/Viatris) to treat presbyopia.Read more
November 17th, 2026Alberta expands optometry scope to include laser proceduresTrained Alberta optometrists may now perform SLT, peripheral iridotomy, and YAG capsulotomy in the office.Read more
November 14th, 2026Takeaways from this week in optometry: November 9-13For Veterans Day, this week’s recap spotlights veterans’ eye care, plus a GLP-1 label change and VR perimetry for glaucoma.Read more
November 12th, 2026Scope Health launches Optase Heat Mask Pro for MGD and dry eyeThe reusable moist heat mask gives ODs another at-home option for patients seeking dry eye and MGD symptom relief.Read more
November 11th, 2026Jarett Mazzarella, OD, on his career as a VA optometristJarett Mazzarella, OD, discusses his path to VA optometry, common eye conditions in veterans, and advice for ODs considering VA.Read more